ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 16 analysts with an average price target of $16.06. This is a potential upside of $13.06 (435.33%) from yesterday's end of day stock price of $3.

Allogene Therapeutics's activity chart (see below) currently has 96 price targets and 110 ratings on display. The stock rating distribution of ALLO is 81.4% BUY, 16.28% HOLD and 2.33% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.4% with an average time for these price targets to be met of 80.79 days.

Highest price target for ALLO is $17, Lowest price target is $4.6, average price target is $16.06.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 16-May-2024. First documented stock forecast 05-Nov-2018.

Currently out of the existing stock ratings of ALLO, 35 are a BUY (81.4%), 7 are a HOLD (16.28%), 1 are a SELL (2.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9

$6.17 (218.02%)

10

2 months 10 days ago

0/6 (0%)

$5.99 (199.00%)

Buy

17

$14.17 (500.71%)

2 months 11 days ago

2/10 (20%)

$14.02 (470.47%)

94

Hold

4.6

$1.77 (62.54%)

5

2 months 12 days ago

3/8 (37.5%)

$1.64 (55.41%)

11

Buy

8

$5.17 (182.69%)

9

4 months 29 days ago

0/3 (0%)

$2.86 (55.64%)

Buy

10

$7.17 (253.36%)

12

6 months 7 days ago

1/7 (14.29%)

$6.91 (223.62%)

28

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 80.79 days on average for the stock forecasts to be realized with a an average price target met ratio 25.4

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Mark Breidenbach has 25 price targets and 14 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Luca Issi with highest potential upside - $29.17

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Dane Leone with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?